Figure 2.
HZ cases avoided with RZV vaccination per one million people over the respective age cohorts’ lifetime, compared with no vaccination, in the mass vaccination setting (base case). HZ: herpes zoster; RZV: recombinant zoster vaccine; YOA: years of age. Step increases over time (particularly pronounced in the 50–59 YOA cohort) are due to incidence being included as an age-specific step function